Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fielding

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2024
Community-level variation in TB testing history in Blantyre, MalawiE S Nightingale, H R A Feasey, M Khundi, et al.
British Journal of Cancer|June 1, 2001
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancerC A Maxwell-Armstrong, L G Durrant, T J Buckley, et al.
Blood|May 15, 2014
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biologyBella Patel, Aditi Dey, Anna Z Castleton, et al.
Leukemia|August 3, 2016
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trialB Patel, A A Kirkwood, A Dey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
British Journal of Haematology|October 30, 2009
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993Bella Patel, Lena Rai, Georgina Buck, et al.
The Journal of Allergy and Clinical Immunology|September 21, 2011
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiencyMarta Rizzi, Carla Neumann, Adele K Fielding, et al.
The European Respiratory Journal|July 2, 2011
Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithmsM X Rangaka, H P Gideon, K A Wilkinson, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 2, 2024
Community-level variation in TB testing history in Blantyre, MalawiE S Nightingale, H R A Feasey, M Khundi, et al.
British Journal of Cancer|June 1, 2001
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancerC A Maxwell-Armstrong, L G Durrant, T J Buckley, et al.
Blood|May 15, 2014
Mouse xenograft modeling of human adult acute lymphoblastic leukemia provides mechanistic insights into adult LIC biologyBella Patel, Aditi Dey, Anna Z Castleton, et al.
Leukemia|August 3, 2016
Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trialB Patel, A A Kirkwood, A Dey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2017
Complete Hematologic and Molecular Response in Adult Patients With Relapsed/Refractory Philadelphia Chromosome-Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment With Blinatumomab: Results From a Phase II, Single-Arm, Multicenter StudyGiovanni Martinelli, Nicolas Boissel, Patrice Chevallier, et al.
Frontiers in Pharmacology|March 27, 2020
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content ValidityPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Therapeutic Advances in Hematology|October 26, 2020
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative studyPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
British Journal of Haematology|October 30, 2009
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993Bella Patel, Lena Rai, Georgina Buck, et al.
The Journal of Allergy and Clinical Immunology|September 21, 2011
Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiencyMarta Rizzi, Carla Neumann, Adele K Fielding, et al.
The European Respiratory Journal|July 2, 2011
Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithmsM X Rangaka, H P Gideon, K A Wilkinson, et al.
Pageof 17